AzTrials
AzTrials

HealthyHOME-FITNCT06983574

Effectiveness of an mHealth Application to Promote Home-Based Exercise in Adults Aged 65 and Older

A study testing MIA in people with Healthy, run by PXL University College.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if drug ABC works to evaluate the effectiveness of an mHealth application to promote home-based exercise in adults aged 65 and older. The objectives are: Primary objective: To evaluate the effect of the mHealth application on increasing moderate-to-vigorous physical activity… Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
MIA
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
No sites listed yet
Study dates
Oct 2025to Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • 65 years or older
  • Medically stable Any existing chronic illnesses (e.g., hypertension, diabetes, or arthritis) are being effectively managed with medications or lifestyle interventions.
  • The participant is not experiencing any recent or ongoing acute medical conditions, such as infections, recent surgeries, or injuries, that could interfere with participation in the study.
  • No significant cognitive, mental or physical impairment that would prevent safe use of the mHealth application or performance of the exercises.
  • Understanding and speaking Dutch
  • Access to a smartphone and computer.

Who cannot join

  • The presence of an active lifestyle.
  • Enrolment in other exercise programs or clinical trials that might interfere with study participation or outcomes.
  • Any condition or circumstance deemed by a healthcare professional to pose a risk to the participant's safety or the validity of the study.

About this study

Official title: Evaluating the Effectiveness of an mHealth Application to Promote Home-Based Exercise in Adults Aged 65 and Older: A Randomized Controlled Trial

The goal of this clinical trial is to learn if drug ABC works to evaluate the effectiveness of an mHealth application to promote home-based exercise in adults aged 65 and older. The objectives are:

Primary objective:

Read more
  • To evaluate the effect of the mHealth application on increasing moderate-to-vigorous physical activity levels.

Secondary objectives:

  • To assess the impact of the mHealth application on physical fitness measures (e.g., functional capacity, strength, balance, fall risk, flexibility)
  • To assess the impact of the mHealth application on physical activity (e.g., daily steps, self-reported physical activity)
  • To examine the impact of the mHealth application on wellbeing
  • To explore the impact of the mHealth application on cognitive functioning
  • To measure user adherence and engagement with the mHealth application
  • To evaluate participant satisfaction with the mHealth application

Researchers will compare a group using an mHealth application to a group not using the application to determine whether it effectively increases physical activity.

Participants will:

  • Use the mHealth application or not for 8 weeks
  • Visit the labo 3 times in total for assessements
  • Use a wearable during the study period
Conditions
Healthy
Being tested
MIA

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MIAOther

    Through a collaborative co-creation process, MIA, a mHealth app was developed and refined over multiple iterations with the goal of promoting physical activity and fostering a lifestyle centred around an active and healthy approach. Content and design were derived from both the co-creative workshops and based on the theoretical framework of the intervention functions of the BCW. The final mHealth app is composed by five major features:

    • Tailor-made tips
    • Literacy aiming to improve awareness about PA and an active healthy lifestyle
    • Exercise workouts
    • Community calendar aiming to enhance social connections
    • A diary consisting of daily activities (MIA workouts and self-registration) To customize the user experience, a brief personal description was created as the start screen, which prompts older adults to answer questions related to their baseline physical activity level, motivation, and medical history.
Study groups in NCT06983574
Study groupRoleWhat they receive
MIA interventionExperimentalParticipants will use the mHealth app to engage in home-based workouts aimed at promoting physical activity. The app provides exercises lasting approximately 12-15 minutes each, which participants are encouraged to perform regularly to achieve a total of at least 150 minutes of moderate-to-vigorous physical activity per week. The intervention period spans 8 weeks, during which participants should follow the app's guidance to complete the recommended workouts and track their progress. Participan
Receives: Other: MIA
No intervention with MIANo interventionParticipants in the control group will be instructed to maintain their usual physical activity, dietary habits, and sleep patterns for the 8-week study duration. They will be asked to refrain from engaging in any specialized exercise training during this time.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MVPA

    Moderate-to-vigorous physical activity (MVPA) will be assessed using a wearable activity tracker, the Garmin Vivomart 5, which allows for continuous, 24/7 monitoring of physical activity. This device tracks various types of movement throughout the day, providing comprehensive data on activity levels and enabling detailed analysis of participants' physical activity patterns over time.

    Measured: From enrollment to 3 months post-intervention

Secondary outcomes (19)
  1. Gait speed

    Gait speed will be measured using the Six Minute Walking Test performed according to the ERS/ATS (22). The absolute distance walked in the test will be used for analysis, and compared with normative values.

    Measured: From enrollment to the end of intervention at 8 weeks

  2. Quadriceps force

    Isometric quadriceps force will be assessed using the Kinvent®2016 (Kinvent, Montpellier, France) handheld dynamometer. Participants will be tested while sitting in an upright position. The assessor applies resistance and askes the participant to maximally contract the muscle against the resistance. At least three maximal efforts will be performed and the test will be repeated until reproducible measurements (less than 10 % variability) are obtained. The highest value will be used for analyses and compared with normative values.

    Measured: From enrollment to the end of intervention at 8 weeks

  3. Handgrip strength

    Handgrip strength will be measured isometrically using the K-Force Grip® (Kinvent, Montpellier, France) while sitting in the upright position with the elbow flexed 90◦ and the wrist in a neutral position. Three maximal efforts will be performed and repeated until reproducible measurements (less than 10 % variability) will be obtained. The highest value will be used for analysis and compared with normative values.

    Measured: From enrollment to the end of intervention at 8 weeks

  4. Balance

    Postural balance will be assessed using the Kinvent PLATES v3® (Kinvent, Montpellier, France). Participants will undergo a double leg balance test three times for 10 seconds with eyes opened and eyes closed, followed by a single leg balance test consisting of three repetitions for each leg with eyes opened.

    Measured: From enrollment to the end of intervention at 8 weeks

  5. Fall risk

    The Timed Up \& Go test will be conducted to evaluate fall risk. Participants will be observed and timed as they stand up from an armchair, walk three meters, turn around, walk back, and sit down again.

    Measured: From enrollment to the end of intervention at 8 weeks

  6. Flexibility

    The Sit and Reach test will assess the spinal flexibility and hamstring length/flexibility. Participants will be seated on the floor with their legs extended and feet placed flat against a sit-and-reach box. A measuring scale will be attached to the top of the box. With their hands placed on top of the other, participants will be instructed to reach forward toward their toes as far as possible. The distance reached will be recorded using the measuring scale. The highest value will be used for analysis.

    Measured: From enrollment to the end of intervention at 8 weeks

  7. Muscle power

    Muscle power will be assessed by the 30 s Sit-to-stand (STS) muscle power test. Briefly, the subjects will perform as many STS repetitions as possible in 30 s on a standardized armless chair from the sitting position-buttocks touching the chair-to the full standing position, with their arms crossed over the chest. Verbal encouragement will be given throughout the test. The participants will be allowed to try one to two times before the definitive measure was annotated.

    Measured: From enrollment to the end of intervention at 8 weeks

  8. Daily steps

    Daily steps will be assessed using a wearable activity tracker, the Garmin Vivomart 5.

    Measured: From enrollment to 3 months post-intervention

  9. IPAQ-SF

    The International Physical Activity Questionnaire - Short Form. The total score will be classified into three categories: low, moderate, and high physical activity, according to the IPAQ scoring guidelines.

    Measured: From enrollment to the end of intervention at 8 weeks

  10. ESES

    The Exercise Self-Efficacy Scale. The total score ranges between 10 and 40. Higher scores represent higher confidence to carry out physycial activity.

    Measured: From enrollment to the end of intervention at 8 weeks

  11. BREQ

    The Behavioural Regulations in Exercise Questionnaire. The total score will be transformed to a RAI score. Higher score represent higher self determination for physical activity.

    Measured: From enrollment to the end of intervention at 8 weeks

  12. PACES

    The Physical Activity Enjoyment Scale. The total score ranges between 8 and 56. Higher scores represent greater enjoyment for physical activity.

    Measured: From enrollment to the end of intervention at 8 weeks

  13. Cognitive function

    The assessment of cognitive functioning will be conducted using the SWAY (SWAY Medical Inc. in Tulsa, OK, USA). The cognitive performance segment of the app encompasses three modules focusing on memory, reaction time, and impulse control. Based on the results, participants will be classified into percentiles ranging from vary low (<10%) to very high (>10%).

    Measured: From enrollment to the end of intervention at 8 weeks

  14. WHO-QoL

    The World Health Organization Quality of Life questionnaire. The total score ranges between 0 and 100. Higher scores represent higher quality of life.

    Measured: From enrollment to the end of intervention at 8 weeks

  15. PSS

    The Perceived Stress Scale. The total score ranges between 0 and 40. Higher scores represent higher perceived stress.

    Measured: From enrollment to the end of intervention at 8 weeks

  16. GSQ

    The Geriatric Sleep Questionnaire. The total score ranges between 6 and 30. Higher scores represent poorer sleep quality.

    Measured: From enrollment to the end of intervention at 8 weeks

  17. SUS

    The System Usability Scale. The total score ranges between 1 and 100. Higher scores represent high usability.

    Measured: From enrollment to the end of intervention at 8 weeks

  18. NPS

    The Net Promoter Score. Total score ranges between 1 and 10. Higher scores represent higher loyalty.

    Measured: From enrollment to the end of intervention at 8 weeks

  19. CSAT

    The Customer Satisfaction Score. Total score ranges between 1 and 5. Higher scores represent higher satisfaction.

    Measured: From enrollment to the end of intervention at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2025
  2. Study startOct 2025 (estimated)
  3. Primary completionMar 2027 (estimated)
  4. Study completionOct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06983574
Sponsor's protocol ID
HOME-FIT
Acronym
HOME-FIT
Status last verified
May 2025
First submitted
12 May 2025
Last updated
21 May 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Quadflieg K, Robijns J, Daniels K. Evaluating the effectiveness of an mHealth application to promote home-based exercise in adults aged 65 years and older: protocol for a randomised controlled trial. BMJ Open. 2025 Nov 4;15(11):e106629. doi: 10.1136/bmjopen-2025-106629.

    PubMed 41193218

Questions about this trial

What is this clinical trial studying?

A study testing MIA in people with Healthy, run by PXL University College.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 21 May 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MVPA (time frame: From enrollment to 3 months post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06983574, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in